About: Evidence of a significant secretory-IgA-dominant SARS-CoV-2 immune response in human milk following recovery from COVID-19

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Evidence of a significant secretory-IgA-dominant SARS-CoV-2 immune response in human milk following recovery from COVID-19 Goto Sponge NotDistinct Permalink

An Entity of Type : schema:ScholarlyArticle, within Data Space : wasabi.inria.fr associated with source document(s)

Attributes	Values
type	Academic Article research paper schema:ScholarlyArticle
isDefinedBy	Covid-on-the-Web dataset
has title	Evidence of a significant secretory-IgA-dominant SARS-CoV-2 immune response in human milk following recovery from COVID-19
Creator	Krammer, Florian Zolla-Pazner, Susan Powell, Rebecca Fox, Alisa Amanat, Fatima Hahn-Holbrook, Jennifer Marino, Jessica
Source	MedRxiv
abstract	SARS-CoV-2, commonly termed COVID-19 for the illness it causes, has infected >3.2 million people, including >220,000 deaths. Human milk IgG originates mainly from blood, therefore a SARS-CoV-2-reactive antibody (Ab) response in milk would be expected (1). However, IgG comprises only ~2% of milk Ab, with most milk Abs originating from mucosa-associated lymphatic tissue (1). Therefore, the extent of the milk immune response to SARS-CoV-2 is unknown (2). This response is critical for infants and young children, who tend not to suffer greatly from COVID-19 pathology but are likely responsible for significant virus transmission (3-5). Perhaps even more significant is the fact that milk Abs could be purified and used as a COVID-19 therapeutic, given they would likely be of the secretory (s) class and highly resistant to proteolytic degradation in the respiratory tissue (2, 6). In this preliminary report, 15 milk samples obtained from donors previously-infected with SARS-CoV-2 as well as 10 negative control samples obtained prior to December 2019 were tested for reactivity to the Receptor Binding Domain (RBD) of the SARS-CoV-2 Spike protein by ELISAs measuring IgA, IgG, IgM, and secretory Ab. Eighty percent of samples obtained post-COVID-19 exhibited IgA reactivity, and all these samples were also positive for secretory Ab reactivity, suggesting the IgA is predominantly sIgA. COVID-19 group mean OD values of undiluted milk were significantly greater for IgA (p<0.0001), secretory-type Abs (p<0.0001), and IgG (p=0.017), but not for IgM, compared to pre-pandemic group mean values. Overall, these data indicate that there is strong sIgA-dominant SARS-CoV-2 immune response in human milk after infection in the majority of individuals, and that a comprehensive study of this response is highly warranted.
has issue date	2020-05-08(xsd:dateTime)
bibo:doi	10.1101/2020.05.04.20089995
has license	medrxiv
sha1sum (hex)	770484339ac9c97879313d50a4ab4bc5408c4085
schema:url	https://doi.org/10.1101/2020.05.04.20089995
resource representing a document's title	Evidence of a significant secretory-IgA-dominant SARS-CoV-2 immune response in human milk following recovery from COVID-19
resource representing a document's body	covid:770484339ac9c97879313d50a4ab4bc5408c4085#body_text
is schema:about of	named entity 'immune response' named entity 'MUCOSA' named entity 'COVID-19' named entity 'MILLION' named entity 'HUMAN MILK' named entity 'milk' named entity 'IgG' named entity 'milk' named entity 'Human milk' named entity 'antibody' named entity 'milk' named entity 'SARS-CoV-2' named entity 'milk' named entity 'immune response' named entity 'SARS' named entity 'IgG' named entity 'cord blood' named entity 'mucosal' named entity 'Milk' named entity 'IgM' named entity 'incubation' named entity 'Milk' named entity 'mice' named entity 'SARS' named entity 'IgG' named entity 'pathology' named entity 'Receptor Binding Domain' named entity 'IgA' named entity 'human milk' named entity 'milk' named entity 'milk' named entity 'RBD' named entity 'SARS-CoV-2' named entity 'diarrhea' named entity 'GALT' named entity 'IgG' named entity 'week of pregnancy' named entity 'pregnant women' named entity 'peer review' named entity 'milk' named entity 'IgM' named entity 'negative control' named entity 'PBS' named entity 'antibodies' named entity 'Spearman correlation' named entity 'centrifuged' named entity 'week of pregnancy' named entity 'pIgR' named entity 'IgM' named entity 'peer review' named entity 'SARS-CoV-2' named entity 'high levels' named entity 'human milk' named entity 'breastfeeding' named entity 'serum' named entity 'serum' named entity 'IgM' named entity 'immune response' named entity 'CC-BY-NC-ND 4.0' named entity 'milk powder' named entity 'milk' named entity 'milk' named entity 'milk' named entity 'COVID' named entity 'milk' named entity 'COVID-19' named entity 'IgG' named entity 'milk' named entity 'IgA' named entity 'SARS-CoV-2' named entity 'milk' named entity 'medRxiv' named entity 'medRxiv' named entity 'IgA' named entity 'IgM' named entity 'mammary gland' named entity 'milk' named entity 'medRxiv' named entity 'milk'

Faceted Search & Find service v1.13.91 as of Mar 24 2020

Alternative Linked Data Documents: Sponger | ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3229 as of Jul 10 2020, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (94 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software